Abstract:Conventional drug screening typically employs either target-based or cell-based approaches. The first group rely on biochemical assays to detect modulators of a purified target. However, hits frequently lack drug-like characteristics such as membrane permeability and target specificity. Cell-based screens identify compounds that induce a desired phenotype, but the target is unknown, which severely restricts further development and optimization. To address these issues, we have developed a second-generation target-based whole-cell screening approach that incorporates the principles of both chemical genetics and competitive fitness, which enables the identification of target-specific and physiologically active compounds from a single screen. We have chosen to validate this approach using the important human fungal pathogen Candida albicans with the intention of pursuing novel antifungal targets. However, this approach is broadly applicable and is expected to dramatically reduce the time and resources required to progress from screening hit to lead compound. ABSTRACT Traditional approaches to drug discovery are frustratingly inefficient and have several key limitations that severely constrain our capacity to rapidly identify and develop novel experimental therapeutics. To address this, we have devised a second-generation target-based whole-cell screening assay based on the principles of competitive fitness, which can rapidly identify target-specific and physiologically active compounds. Briefly, strains expressing high, intermediate, and low levels of a preselected target protein are constructed, tagged with spectrally distinct fluorescent proteins (FPs), and pooled. The pooled strains are then grown in the presence of various small molecules, and the relative growth of each strain within the mixed culture is compared by measuring the intensity of the corresponding FP tags. Chemical-induced population shifts indicate that the bioactivity of a small molecule is dependent upon the target protein’s abundance and thus establish a specific functional interaction. Here, we describe the molecular tools required to apply this technique in the prevalent human fungal pathogen Candida albicans and validate the approach using two well-characterized drug targets—lanosterol demethylase and dihydrofolate reductase. However, our approach, which we have termed target abundance-based fitness screening (TAFiS), should be applicable to a wide array of molecular targets and in essentially any genetically tractable microbe. IMPORTANCE Conventional drug screening typically employs either target-based or cell-based approaches. The first group relies on biochemical assays to detect modulators of a purified target. However, hits frequently lack drug-like characteristics such as membrane permeability and target specificity. Cell-based screens identify compounds that induce a desired phenotype, but the target is unknown, which severely restricts further development and optimization. To address these issues, we have developed a second-generation target-based whole-cell screening approach that incorporates the principles of both chemical genetics and competitive fitness, which enables the identification of target-specific and physiologically active compounds from a single screen. We have chosen to validate this approach using the important human fungal pathogen Candida albicans with the intention of pursuing novel antifungal targets. However, this approach is broadly applicable and is expected to dramatically reduce the time and resources required to progress from screening hit to lead compound.

Application of incremental change strategies in chiropractic and multidisciplinary clinical settings for quality improvement.

Radiologic assessment of maxillofacial, mandibular, and skull base trauma

Three-dimensional visualization of gunshot cavities in ballistic gelatine with computed tomography - A forensic ballistics case study

[Gunshot wounds of the abdomen studied by computed tomography. The authors' personal experience in 30 cases]

Civilian gunshot wounds to the head: a case report, clinical management, and literature review

Effects of kinetic energy and firearm‐to‐target distance on fracture behavior in flat bones

Comparative Study of Computerized Tomography Imaging of Facial Trauma Using 2D and 3D Reconstruction Scans

Cranial trauma in handgun executions: Circumferential delamination defect and its relationship with contact/close‐range shooting

ACR Appropriateness Criteria® Penetrating Torso Trauma

Gunshot Wounds to the Head: 29 Cases of Monocenter Children's Trauma Hospital Experience and Predictor Scales in Pediatric Population

On the Measurement of Hospital Case Mix

Cerebrovascular Injury Caused by a High Strain Rate Insult in the Thorax

Can ultra-low-dose computed tomography reliably diagnose and classify maxillofacial fractures in the clinical routine?

Target Abundance-Based Fitness Screening (TAFiS) Facilitates Rapid Identification of Target-Specific and Physiologically Active Chemical Probes

[Forensic-radiological diagnosis of gunshot wounds]

Comparison of In-Hospital Mortality and Neurosurgical Intervention Between Intracranial Gunshot Wounds Arising From Long Guns and Handguns: A Propensity Score Matched Study

Clinical, radiological, and laboratory factors associated with mortality and functional outcomes in pediatric patients presenting with intracranial gunshot wounds

Acute Development of Traumatic Intracranial Aneurysms Following Civilian Gunshot Wounds to the Head

Diagnostic imaging: oral and maxillofacial fractures

GRANULOMA INGUINALE IN NORTHERN QUEENSLAND

Treatment of Penetrating Nonmissile Traumatic Brain Injury. Case Series and Review of the Literature